Grantham, Mayo, Van Otterloo & Co (GMO)’s National Healthcare NHC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,917	Closed	-$304K	–	648
2023 Q2	$304K	Buy	4,917 +917	+23%	+$54.4K	﹤0.01%	603
2023 Q1	$232K	Hold	4,000	–	–	﹤0.01%	638
2022 Q4	$238K	Sell	4,000 -700	-15%	-$42.4K	﹤0.01%	658
2022 Q3	$298K	Sell	4,700 -3,800	-45%	-$264K	﹤0.01%	632
2022 Q2	$594K	Hold	8,500	–	–	﹤0.01%	589
2022 Q1	$597K	Buy	+8,500	New	+$572K	﹤0.01%	585

Other funds holding NHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NHC Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of National Healthcare (NHC) in Q3 2023, closing a stake of 4,917 shares — an estimated $304K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NHC in Q1 2022 and held it in 6 quarters. The position peaked at $597K in Q1 2022. 131 funds tracked by Wall St. Rank hold NHC as of Q3 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining National Healthcare position as of Q3 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,917 National Healthcare shares in Q3 2023, an estimated $304K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in National Healthcare in Q1 2022 and held it in 6 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s National Healthcare position peaked at $597K in Q1 2022.
131 funds tracked by Wall St. Rank held National Healthcare as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.